Please do not close or refresh this window...
Wednesday, Jun 15, 2016 at 10:00 AM to 11:00 AM EST
Access code applied successfully. Remove
Invalid access code. Try again
The FDA’s Center for Drug Evaluation and Research (CDER) is responsible for reviewing and approving both prescription and nonprescription or over-the-counter (OTC) drugs.
To introduce a new drug product into the U.S. market, some firms submit a new drug application (NDA) to the US FDA/CDER.
The firms are responsible for testing a drug and for submitting evidence that the drug is safe and effective.
In 2014 and 2015, the FDA/CDER has approved 41 and 45 novel drugs, respectively.
This webinar is intended to help you better understand FDA’s drug review and approval process. The FDA’s recent approvals of novel drugs will also be discussed.
The speaker will walk you through the regulatory requirements for FDA’s drug review and approvals.
For more details :- https://www.grcts.com/GRC-90024
http://www.grcts.com
GRC Training Solutions is a premier training and solutions company that conducts high impact trainings in Corporate Governance, Regulatory Compliance, Quality Management and Risk Management. GRCs training modules are designed and facilitated by industry experts who possess a strong theoretical and working knowledge of the required regulatory compliance requirements. GRC Training Solutions uses Government and industry best practices and relevant software tools to help companies of all sizes accelerate business performance by helping them understand how to effectively operate within the various guidelines and regulatory frameworks.The training modules are designed for senior and mid level management and executives.
This event is currently unable to accept new registrations
Please enter below, the secure invite code provided to you by the event organizer in order to proceed...
(Please use a genuine email address. It will be used to validate your request)